New-generation positional therapy in patients with positional central sleep apnea
- 16 Downloads
To evaluate the effect of a sleep position trainer (SPT) in patients with positional central sleep apnea (PCSA).
A multicentre cohort study was conducted. Patients with symptomatic PCSA were included. Effectiveness, compliance and quality of life were assessed at 1- and 6-month follow-up.
Sixteen patients were included. Median AHI dropped from 23.4/h [12.9–31.2] to 11.5/h [7.2–24.5] (p = 0.044) after 1-month SPT therapy and in patients who continued treatment, median AHI further decreased after 6 months to 9.7/h [3.4–27.6] (p = 0.075). Median percentage of supine sleep decreased significantly from 37.6 [17.2–51.8] to 6.7 [0.7–22.8] (p < 0.001), after 1 month, and to 6.8 [0.7–22.1] (p = 0.001), after 6 months. Mean compliance over 1 and 6 months was 78.6 ± 35.3 and 66.0 ± 33.3%, respectively. Epworth Sleepiness Scale at baseline was 9.5 [3.3–11.8] and did not significantly decrease after 1 month (11.0 [3.0–13.0]) and 6 months (4.0 [3.0–10.5]) follow-up. Functional Outcomes of Sleep Questionnaire remained stable within the first month. However, after 6 months, there was a significant improvement compared to baseline values, 15.9 [11.9–18.4] vs. 17.8 [14.3–19.2]; p = 0.030.
This is the first study on effects of positional therapy with a new-generation smart device in patients with PCSA after 1 and 6 months of follow-up. Results of this study show that the SPT is effective in reducing AHI and central AI, feasible in PCSA, and is associated with symptomatic improvement. While the working mechanism behind this effect remains speculative, the effect is positive and considerable.
KeywordsSleep-disordered breathing Sleep apnea Positional central sleep apnea Positional therapy Sleep position trainer
NightBalance provided the 16 SPT devices.
Compliance with ethical standards
Conflict of interest
Prof. Dr. N. de Vries is a member of the Medical Advisory Board of NightBalance. He is also an investigator of Inspire and Jazz Pharmaceutics, consultant of Philips, Olympus and the AE Mann Foundation. Prof. Dr. J. Verbraecken is a member of the Medical Advisory Boards of ResMed Narval and Bioprojet. He is also a consultant of Philips and Jazz Pharmaceutics, and an investigator of ResMed. All the other authors declare that they have no conflicts of interest or financial ties to disclose. Dr. L.B.L. Benoist, Dr. P.E. Vonk, and Dr. H.C.J.P. Janssen declare that they have no conflict of interest.
Research involving human participants
All the procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 2.Randerath W, Verbraecken J, Andreas S, Arzt M, Bloch KE, Brack T, Buyse B, De Backer W, Eckert DJ, Grote L, Hagmeyer L, Hedner J, Jennum P, La Rovere MT, Miltz C, McNicholas WT, Montserrat J, Naughton M, Pepin JL, Pevernagie D, Sanner B, Testelmans D, Tonia T, Vrijsen B, Wijkstra P, Levy P (2017) Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. Eur Respir J. https://doi.org/10.1183/13993003.00959-2016 Google Scholar
- 5.Muza RT (2015) Central sleep apnoea-a clinical review. J Thorac Dis 7(5):930–937. https://doi.org/10.3978/j.issn.2072-1439.2015.04.45 Google Scholar
- 14.Ravesloot MJL, White D, Heinzer R, Oksenberg A, Pepin JL (2017) Efficacy of the new generation of devices for positional therapy for patients with positional obstructive sleep apnea: a systematic review of the literature and meta-analysis. J Clin Sleep Med 13(6):813–824. https://doi.org/10.5664/jcsm.6622 CrossRefGoogle Scholar
- 17.Dieltjens M, Vroegop AV, Verbruggen AE, Wouters K, Willemen M, De Backer WA, Verbraecken JA, Van de Heyning PH, Braem MJ, de Vries N, Vanderveken OM (2015) A promising concept of combination therapy for positional obstructive sleep apnea. Sleep Breath 19(2):637–644. https://doi.org/10.1007/s11325-014-1068-8 CrossRefGoogle Scholar
- 21.Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, Marcus CL, Mehra R, Parthasarathy S, Quan SF, Redline S, Strohl KP, Davidson Ward SL, Tangredi MM, American Academy of Sleep M (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 8(5):597–619. https://doi.org/10.5664/jcsm.2172 Google Scholar
- 24.Leemans G, Ides K, Van Holsbeke C, Vissers D, Vos W, De Backer W (2013) The influence of posture on airway structure and function in healthy subjects. Eur Respir SocGoogle Scholar
- 26.Hazebroek EJ, Bonjer HJ (2006) Effect of patient position on cardiovascular and pulmonary function. In: Whelan RL, Fleshman JW, Fowler DL (eds) The SAGES manual of perioperative care in minimally invasive surgery, 1 edn. Springer, Berlin, pp 410–417. https://doi.org/10.1007/0-387-29050-8 Google Scholar
- 32.Galetke W, Ghassemi BM, Priegnitz C, Stieglitz S, Anduleit N, Richter K, Randerath WJ (2014) Anticyclic modulated ventilation versus continuous positive airway pressure in patients with coexisting obstructive sleep apnea and Cheyne–Stokes respiration: a randomized crossover trial. Sleep Med 15(8):874–879. https://doi.org/10.1016/j.sleep.2014.02.012 CrossRefGoogle Scholar
- 35.Verbraecken J, Willemen M, Wittesaele W, Van de Heyning P, De Backer W (2002) Short-term CPAP does not influence the increased CO. Monaldi Arch Chest Dis 57(1):10–18Google Scholar